[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335248-105":59,"doc-detail-335248-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","crossing-epigenetic-frontiers-the-intersection-of-novel-histone-modifications-and-diseases","Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases","","Histone post-translational modifications (HPTMs) are central to epigenetic regulation and are increasingly linked to disease onset and progression, making them promising targets for precision therapy. Advances in high-throughput molecular tools and bioinformatics have enabled the discovery of multiple novel HPTMs that modulate gene expression, metabolism, and chromatin architecture. This review defines nine novel HPTMs and details their roles in transcription, replication, DNA repair and recombination, metabolism, and chromatin structure, including their contributions across cancers, cardiovascular disease, infections, psychiatric disorders, and reproductive system diseases, alongside therapeutic and biomarker applications. It also surveys inhibitors and emerging clinical strategies, and briefly introduces novel epigenetic research techniques.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/crossing-epigenetic-frontiers-the-intersection-of-novel-histone-modifications-and-diseases/335248/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/crossing-epigenetic-frontiers-the-intersection-of-novel-histone-modifications-and-diseases/335248.png","ImageObject",300,407,{"name":92,"@type":93},"Levi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What are histone post-translational modifications (HPTMs) and why are they important in epigenetics?","Question",{"text":112,"@type":113},"HPTMs regulate chromatin structure and influence how genetic information is expressed and interpreted. They provide an additional layer of control that helps cells respond flexibly to external stimuli and environmental changes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which novel histone modifications are covered in the review?",{"text":117,"@type":113},"The review defines nine novel histone modifications: lactylation, citrullination, crotonylation, succinylation, SUMOylation, propionylation, butyrylation, 2-hydroxyisobutyrylation, and 2-hydroxybutyrylation.",{"name":119,"@type":110,"acceptedAnswer":120},"How does this review connect novel HPTMs to therapeutic opportunities?",{"text":121,"@type":113},"It links these modifications to disease development across multiple conditions and discusses clinical applications where HPTM inhibitors target various pathways, potentially also serving as biomarkers and contributing to emerging treatment strategies.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335248,1791204394,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Signal Transduction [and Targeted Therapy](and Targeted Therapy www.nature.com/sigtrans)[ www.nature.com/sigtrans](and Targeted Therapy www.nature.com/sigtrans)  \nREVIEW ARTICLE  \nOPEN  \nCrossing epigenetic frontiers: the intersection of novel histone modiﬁcations and diseases  \nWeiyi Yao 1, Xinting Hu 1,2 ✉ and Xin Wang 1,2,3 ✉  \n\n| | Histone post-translational modiﬁcations (HPTMs), as one of the core mechanisms of epigenetic regulation, are garnering increasing attention due to their close association with the onset and progression of diseases and their potential as targeted therapeutic agents. Advances in high-throughput molecular tools and the abundance of bioinformatics data have led to the discovery of novel HPTMs which similarly affect gene expression, metabolism, and chromatin structure. Furthermore, a growing body of research has demonstrated that novel histone modiﬁcations also play crucial roles in the development and progression of various diseases, including various cancers, cardiovascular diseases, infectious diseases, psychiatric disorders, and reproductive system diseases. This review deﬁnes nine novel histone modiﬁcations: lactylation, citrullination, crotonylation, succinylation, SUMOylation, propionylation, butyrylation, 2-hydroxyisobutyrylation, and 2-hydroxybutyrylation. It comprehensively introduces the modiﬁcation processes of these nine novel HPTMs, their roles in transcription, replication, DNA repair and recombination, metabolism, and chromatin structure, as well as their involvement in promoting the occurrence and development of various diseases and their clinical applications as therapeutic targets and potential biomarkers. Moreover, this review provides a detailed overview of novel HPTM inhibitors targeting various targets and their emerging strategies in the treatment of multiple diseases while offering insights into their future development prospects and challenges. Additionally, we brieﬂy introduce novel epigenetic research techniques | |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  | and their applications in the ﬁeld of novel HPTM research. |  |\n|  |  |  |\n|  |  |  |\n|  | Signal Transduction and Targeted Therapy (2024)9:232 ; [https://doi.org/10.1038/s41392-024-01918-w](https://doi.org/10.1038/s41392-024-01918-w) |  |\n|  |  |  |\n\nINTRODUCTION  \nHistones, as the fundamental building blocks of chromatin, have their functions and characteristics regulated through an intricate and complex array of HPTMs.1 These modiﬁcations work in concert to determine the spatial structure of chromatin and profoundly inﬂuence the expression and interpretation of genetic information.2 The diverse changes brought about by HPTMs offer an additional layer of control over gene expression, enabling cells to respond ﬂexibly to various external stimuli. This adaptability ensures the normal functioning of vital processes while also allowing for rapid reactions to environmental changes.3–5 Proteins undergo various HPTMs that are crucial for chromatin regulation and function, affecting gene expression, chromatin structure, and cellular responses to stimuli. While acetylation (ac) and methylation (ma) are well-studied HPTMs, there has been a recent realization that the functions of many HPTMs remain largely unknown. Newly discovered HPTMs include a range of lysine ac such as propionylation (pr), butyrylation (bu), crotonylation (cr), hydroxyisobutyrylation (hib), succinylation (succ), and ma.6–9 Many of these ac sites coincide with known ac sites, prompting questions regarding the functional similarities between them.10 HPTMs are subject to inﬂuence by external environmental factors and metabolic status, and they possess the ability to signiﬁcantly affect the initiation and progression of a range of conditions, including inﬂammation,11 cancers,12 cardiovascular diseases,13 kidney diseases,14 metabolic diso","cbCaimoBzualWrEz","https://ap.wps.com/l/cbCaimoBzualWrEz","pdf",6899120,38,"English","# Introduction\n# The developmental trajectory of HPTMs\n# Roles of novel HPTMs across cellular processes\n# Novel HPTMs in disease progression\n# Therapeutic targeting: HPTM inhibitors\n# Future prospects and challenges","[{\"question\":\"What are histone post-translational modifications (HPTMs) and why are they important in epigenetics?\",\"answer\":\"HPTMs regulate chromatin structure and influence how genetic information is expressed and interpreted. They provide an additional layer of control that helps cells respond flexibly to external stimuli and environmental changes.\"},{\"question\":\"Which novel histone modifications are covered in the review?\",\"answer\":\"The review defines nine novel histone modifications: lactylation, citrullination, crotonylation, succinylation, SUMOylation, propionylation, butyrylation, 2-hydroxyisobutyrylation, and 2-hydroxybutyrylation.\"},{\"question\":\"How does this review connect novel HPTMs to therapeutic opportunities?\",\"answer\":\"It links these modifications to disease development across multiple conditions and discusses clinical applications where HPTM inhibitors target various pathways, potentially also serving as biomarkers and contributing to emerging treatment strategies.\"}]","Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases | PDF",1790010294,96]